Discovering New Paths For Cancer Solutions
INTRODUCTION
Sortcell Analytica is a spin-off from CIMA, Universidad de Navarra, and was founded to bring to the clinical market non-invasive and easy-to-use systems that isolate viable circulating tumor cells (CTCs) by liquid biopsy directly from whole blood samples. With our systems, we aimed to bridge the gap in early detection, treatment monitoring, relapse detection, and characterization of CTCs to enable personalized treatment.
7+
Years Of Experience
About us
Sortcell Analytica is a spin-off from CIMA, Universidad de Navarra, and was founded to bring to the clinical market non-invasive and easy-to-use systems that isolate viable circulating tumor cells (CTCs) by liquid biopsy directly from whole blood samples. With our systems, we aimed to bridge the gap in early detection, treatment monitoring, relapse detection, and characterization of CTCs to enable personalized treatment.
In addition, we offer our expertise to third parties across several areas. Explore our services to learn more about how we can support your projects.
7+
Years Of Experience
Our Mission
Enable personalized cancer treatment by providing a patient’s peripheral blood test sample. Sortcell Analytica offers a product-based solution for simple, effective and affordable repeat testing of intact cells.
Our Vision
Sortcell Analytica aims to become the undisputed leader in non-invasive cell based applications for simpler, faster and more accurate diagnostic and therapeutic approaches.
Has a need?
Let’s Make It Happen